General Assembly in Amsterdam

On 2 June 2016 the bi-annual General Assembly consortium meeting with representatives from each institution took place in Amsterdam. During this meeting the finalizing of the recruitment phase, the first experiences with the 12 months assessment and boost, and the final touch for the 18 months assessment were discussed. Also the first analyses on the baseline data were presented. It was also time to look ahead on building additional options into the shared data platform and further to utilizing the extensive data collection, beyond the plans that are already there. Also plans are made for future cooperation, beyond HATICE. It was a profitable day, underlining the next phase for HATICE.
From May 9th till May 12th 2016 the second ESOC (European Stroke Organisation Conference) took place in Barcelona, Spain. Edo Richard presented encouraging data on the PreDIVA trial, which illustrated the effect of a multidomain intervention on cognitive functioning in general practice. With more than 3000 attendees this was a perfect opportunity to let the world know about PreDIVA. HATICE was also enthusiastically presented in the poster area with posters on the ‘baseline characteristics HATICE’ and ‘blood pressure variability in PreDIVA’.